Skip to content

Comparison the efficacy of rasa sinex and mometasone nasal sprays on sinusitis

Comparison the efficacy of rasa sinex and mometasone nasal sprays on the symptoms of chronic rhino sinusitis without polyposis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250926067369N1
Enrollment
98
Registered
2026-01-09
Start date
2026-01-25
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic rhino sinusitis without polyposis. Chronic sinusitis

Interventions

Intervention 1: Intervention group: Rasa Sinex nasal spray receiving group.The active ingredient is the black seed plant or Nigella sativa(manufacturer: Salamat Gostar Artiman) and is administered in

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with chronic rhinosinusitis without polyposis

Exclusion criteria

Exclusion criteria: Absence of other chronic disease suffering from incurable diseases contracting diseases such as AIDS history of organ transplantation pregnancy and lactation in women absence of acute respiratory diseases

Design outcomes

Primary

MeasureTime frame
Rate of improvement in chronic rhinosinusitis symptoms based on the lund-mackay. Timepoint: Measuring symptom severity based on Lund-Mackay CT scan index at the beginning of the study and 6 weeks later. Method of measurement: Lund-Mackay CT scan index.;Rate of improvement in chronic rhinosinusitis symptoms based on the SNOT-22 questionnaire. Timepoint: Measurement of symptom severity based on the SNOT-22 questionnaire at the beginning of the study and 6 weeks later. Method of measurement: SNOT-22 questionnaire.;Rate of improvement in chronic rhinosinusitis symptoms based on VAS criteria. Timepoint: Measurement of symptom severity based on VAS criteria at the beginning of the study and 6 weeks later. Method of measurement: VAS criteria.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAshkan Mehrpour

Shahid Beheshti University of Medical Sciences

ashkanmehrpour1368@gmail.com+98 21 5102 5000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026